The furosemide industry is a $3 million annual business for Thoroughbred racing in New York state, regulators said Oct. 26, with the average horse given $500 worth of doses in a typical year.
Churchill Downs announced Sept. 17 that it is working in partnership with other tracks, the Grayson-Jockey Club Research Foundation, and the AAEP to fund studies of the administration of furosemide.
In a survey designed to combat claims that the leaders of horsemen's groups don't represent their membership, the Florida HBPA Sept. 16 released the results of a poll that said most respondents support use of Lasix.
Nearly a month after the California Horse Racing Board hit the brakes on third-party administration of furosemide in the state, the governing body spent just more than a minute to move the process along at a meeting Sept. 16.
How would you handicap 'off-Lasix' horses?
Two research projects designed to study the impact of furosemide on exercise-induced pulmonary hemorrhage will be conducted on behalf of the Grayson-Jockey Club Research Foundation, the organization said Sept. 15.
The California Horse Racing Board Medication and Track Safety Committee took a step forward Sept. 4 regarding potential employment of third-party furosemide administration in the state.
The California Thoroughbred Trainers Aug. 31 said its leadership unanimously agreed to use $150,000 from reserve funds to facilitate race-day camera surveillance in barn areas at California racetracks.
With an eye toward a possible proposal to change New York's rules on the race-day medication furosemide, the state's Gaming Commission met in Saratoga Springs Aug. 25 to solicit opinions about the medication.
At a forum designed to educate state regulators about furosemide, the very people the presentations were designed to enlighten may well have left with more questions than answers.
Two days after delaying steps to begin third-party administration of race-day furosemide, members of the California Horse Racing Board said they're still in support -- in concept -- of the proposal.
A three-year effort to employ third-party administration of the race-day medication furosemide in California was delayed significantly at a California Horse Racing Board meeting Aug. 20 at Del Mar.
Use of race-day furosemide will be the topic for a daylong forum put together by the New York State Gaming Commission Aug. 25 in Saratoga Springs, N.Y.
The opening panel Aug. 11 at the Saratoga Institute on Racing, Equine, and Gaming Law conference set the tone for what figures to be a continued industry battle over federal versus state-by-state regulation.
Marc Summers, vice president and general counsel for The Jockey Club, has prepared a side-by-side comparison of two federal bills that propose creating a national program for managing medication use in racehorses.
A bipartisan bill introduced July 16 in the U.S. House of Representatives would see the U.S. Anti-Doping Agency create an independent organization for oversight of medication issues in horse racing.
A Salix-free race proved so popular at the entry box Wednesday that the over-subscribed field of 2-year-old fillies was split into two races for Saturday's program at Gulfstream Park.
Considering possible changes to the state's equine drug laws, New York regulators are calling together education, veterinary science, and industry experts to discuss the use of the anti-bleeding medicine furosemide.
Gulfstream Park in July plans to experiment with at least two 2-year-old races that will be written for horses that don't compete on race-day furosemide, officials said June 11.
The second day of the inaugural Pan American Conference focused on medication policy and reform.
Florida Gov. Rick Scott June 2 signed into law legislation that will revamp equine medication and drug testing as part of a national movement.
- By Tom LaMarra
United States Rep. Paul Tonko of New York said May 29 he will introduce federal legislation that would grant the United States Anti-Doping Agency oversight of equine medication and drug testing.
A May 6 vote to change the recommended testing threshold for the anti-bleeding medication furosemide when it is administered 24 hours before a race triggered another debate and posed more questions.
Owner Bill Casner hasn't wavered since his 2011 decision to race his Thoroughbreds without the widely used diuretic furosemide, or Salix (Lasix).
The Association of Racing Commissioners International kicked off its 2015 convention April 21 with an emphasis on identifying at-risk racehorses and equine welfare issues.
Trainer Michael Dickinson explains why he has joined the ranks of WHOA members working to pass federal legislation to prohibit the use of performance-enhancing drugs in North American horse racing.
Racing industry officials said they again expect to see federal legislation filed this year that would authorize the United States Anti-Doping Agency to oversee equine medication and drug testing procedures.
The Kentucky Horse Racing Commission March 23 approved a regulation that would permit the state's racetracks to card races that would prohibit the administration of furosemide within 24 hours of post time.
New York regulators March 23 said they want to hold a forum to consider the future use of anti-bleeding medication furosemide in the state.
The Kentucky Horse Racing Commission is considering a proposal that would permit the state's racetracks to card races that would prohibit the administration of furosemide within 24 hours of post time.
Kentucky Equine Research president Joe Pagan, Ph.D., will discuss proper nutrition for horses being treated with Lasix (furosemide, formally called Salix) at a March 16 seminar in Ocala, Fla.
Legislation governing equine medication policy is scheduled to be heard Feb. 18 by the Florida Senate Regulated Industries Committee.
Terry Finley has submitted additional information he says documents a failure by New York Thoroughbred Horsemen's Association staff to publicize its 2014 election to all potential voters.
The New York State Gaming Commission has sanctioned trainer Bill Mott for a pair of medication overages in a single horse last fall, a decision the Racing Hall of Fame conditioner is appealing.
The RMTC said Dec. 9 the Thoroughbred industry has made "major gains" this year in the number of jurisdictions operating or soon to be operating under all or part of the National Uniform Medication Program.
The board of the New York Racing Association Dec. 3 approved the racing corporation's 2015 budget, but not before a spirited debate by some board members over equine drug issues.
Gulfstream Park will begin third-party administration of race-day furosemide beginning Wednesday, Nov. 19.
Ogden Phipps said Oct. 6 a centralized regulatory body for horse racing would facilitate changes necessary to improve the integrity of the sport in the United States, but the chances of it happening are slim to none.
Two of three distinguished veterinarians being honored by the Thoroughbred Club of American, Dr. Larry Bramlage and Dr. Gary Lavin, addressed medication use in racehorses during their acceptance speeches.
The Indiana Horse Racing Commission has summarily suspended a licensed veterinarian and assistant trainer/owner for an alleged illegal race-day injection of a 3-year-old filly before a race at Indiana Grand Racecourse.
Charles J. Cella, president of Oaklawn Racing & Gaming, announced Sept. 18 that the Arkansas track in 2015 will offer purse bonuses for horses that run and win without furosemide (Salix or commonly called Lasix).
Jockey Club says a recent study's findings challenge long-held opinions in North American racing, including the contention that the use of the diuretic furosemide is necessary to ensure long-term careers of horses.
A study published online this spring found no link between the vast majority of horses who suffer from exercise-induced pulmonary hemorrhage and long-term racing performance.
A Kentucky racing official Sept. 12 said the state has been at the forefront of research into cobalt, a naturally occurring element said to have blood-doping qualities if used at high levels.
The Arkansas Racing Commission approved the entire program Sept. 11. Once implemented, Arkansas will become the sixth state to fully administer the Racing Medication and Testing Consortium's National Uniform Medication rules.
Kentucky regulators are considering allowing tracks in the state to card races that would prohibit the administration of race-day furosemide, commonly called Salix or Lasix.
A 12.5% increase in the minimum riding fee scale for losing jockeys in California got an unexpected addition from the state's horse racing board Aug. 21.
The National Horsemen's Benevolent and Protective Association restated its strong support for the continued use of Lasix (furosemide, also commonly called Salix) at its summer convention Aug.15-17 in Oklahoma City.
In response to a statement from 25 prominent horsemen calling for a ban on the race-day use of furosemide, the Florida Horsemen's Benevolent and Protective Association Aug. 8 issued an open letter opposing changes.
Advocates for change in horse racing didn't find much reason for optimism in the National Thoroughbred Racing Association's legislative update held in Saratoga Springs Aug. 7.
Most Popular Stories
- Tonalist Charges to Cigar Mile Victory
- Stormy Lucy Provides Matriarch Stunner
- Mr Speaker Retired, Will Stand at Lane's End
- Del Mar Sees Daily Handle Drop for Fall Meet
- Melmich Breaks Track Record in Valedictory
- Dressed in Hermes Up Late for DeMille Win
- 'All Others' Choice in Pool 1 of KDFW
- Mohaymen Heads South After Remsen Victory
- Casse Has Derby Aspirations for 2-year-olds
- Poshsky Rallies to Take Berkeley Handicap